// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























28841 Abstracts

Right Ventricular Function in Patients with Severe Respiratory Failure Supported with Veno-Venous Extracorporeal Membrane Oxygenation

M. Pichette - American Thoracic Society (ATS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

N/A

N/A

Alveolar Dead Space Fraction and Respiratory System Compliance Predict the Effect of Extracorporeal CO2 Removal on Driving Pressure: Foundation for a Precision Medicine Strategy

E. C. Goligher - American Thoracic Society (ATS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

N/A

Methadone hydrochloride

Organic Dust Extract Induces Nucleocytoplasmic Translocation of High Mobility Group Box 1 (HMGB1) in Human Airway Epithelial Cell Lines

S. Mahadev Bhat - American Thoracic Society (ATS) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

GM-CSF

The Genotype and Phenotype of Mycobacterium Xenopi in Ontario, Canada

T. Hirama - American Thoracic Society (ATS) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Plasminogen Reduces Lung Fibrosis in the Bleomycin-Induced Lung Fibrosis Model

L. Gagnon - American Thoracic Society (ATS) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Pirfenidone

Pulmonary Vascular Engineering Using Induced Endothelial Progenitor-Like Cells

T. Suzuki - American Thoracic Society (ATS) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Doxycycline

Efficient Revascularization of Decellularized Lung Scaffolds by Co-Delivery of Induced Pluripotent Stem Cell (iPSC)-Derived Endothelial and Smooth Muscle Cells

M. Ho - American Thoracic Society (ATS) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Subsolid Nodules in Lung Cancer Screening

R. L. Myers - American Thoracic Society (ATS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

N/A

N/A

Evaluation of the Effect of PBI-4050 Alone or in Combination with Pirfenidone or Nintedanib on Blood Biomarkers Linked to the Fibrotic Process in IPF Patients

L. Gagnon - American Thoracic Society (ATS) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Pirfenidone

Intrapulmonary Human Airway Smooth Muscle Tissues Are Hyperreactive and Hyposensitive in Asthma

G. Ijpma - American Thoracic Society (ATS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

N/A

Isoproterenol

Phenotyping COPD Exacerbations Using Molecular Pathogen Detection Methods

N. M. Alotaibi - American Thoracic Society (ATS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

N/A

N/A

Optimization of COPD Management Among Inpatients with Acute Exacerbations of COPD

I. Wirth - American Thoracic Society (ATS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

N/A

N/A

The Gut Microbiota Promotes Intravascular Immunity Against Bacterial Dissemination During Sepsis

B. McDonald - American Thoracic Society (ATS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

N/A

N/A

Overexpression of IL-10 in Human Umbilical Cord Mesenchymal Stromal/Stem Cells Enhances Efficacy in Rodent E Coli Pneumonia

M. Jerkic - American Thoracic Society (ATS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

N/A

Interleukin-10

Proprotein Convertase Subtilisin/Kexin Type 9 Loss-of-Function Genotype Is Beneficial to Septic Shock Outcome While HMG-CoA Reductase Loss-of-Function Genotype Is Not

H. Kong - American Thoracic Society (ATS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

N/A

vasopressin Injection

The Canadian Healthy Infant Longitudinal Development (child) Birth Cohort: Aeroallergens, Air Pollution and Risk of Atopy and Wheeze

C. Sierra-Heredia - American Thoracic Society (ATS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Obstetrics/Gynecology

N/A

N/A

Household Cleaning Product Use and Respiratory Health in Early Life: An Analysis from the Canadian Healthy Infant Longitudinal Development (CHILD) Study

T. K. Takaro - American Thoracic Society (ATS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

N/A

N/A

Exposure to Air Pollution Worsens Pseudomonas Infection in Cystic Fibrosis Mice

W. Guo - American Thoracic Society (ATS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

N/A

N/A

Does Improved Lung Health Change the Incidence of Cystic Fibrosis-Related Diabetes?

L. Perrem - American Thoracic Society (ATS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

N/A

N/A

Alveolar-Like Macrophages Can Limit Respiratory Syncytial Virus Infection in Mice

T. J. Moraes - American Thoracic Society (ATS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

N/A

Isoflurane

Copyright © 2026. QuantiNova All rights reserved